不同目标平均动脉压对高血压脓毒性休克患者胃肠功能的影响
本研究为前瞻性随机对照研究,纳入柳州市人民医院ICU 2019年1月1日至2020年5月31日收治的208例高血压脓毒性休克患者,随机分为低目标MAP组(LS组,目标65-70 mmHg,109例)和高目标MAP组(HS组,目标75-80 mmHg,99例),均按2016年与2018年更新版拯救脓毒症运动指南给予原发病治疗、液体复苏和支持治疗。结果显示LS组第3、7天AGI分级分布优于HS组,第1、3、7天肠系膜上动脉Vm更高、RI更低,第3、7天MI更高、GET更短,治疗3天后TNF-α、IL-6、PCT、VEGF更低,血管活性药使用天数更短、液体量更少。结论认为高血压脓毒性休克患者维持低目标MAP(65-70 mmHg)可改善肠系膜上动脉血供、保护胃肠功能、降低炎症因子水平并减少血管活性药使用时间和液体量。
要点
- 高血压脓毒性休克患者目标MAP设为65-70 mmHg(LS组)较75-80 mmHg(HS组)第3天AGI I级比例25.69% vs 15.15%、III级11.93% vs 25.25%(χ2=7.900,P=0.048)。
- LS组第1、3、7天肠系膜上动脉Vm均高于HS组(21.72±3.02 vs 19.50±2.83、20.42±2.62 vs 17.02±1.99、26.52±2.70 vs 22.47±4.03 cm/s),RI均低于HS组(0.86±0.05 vs 0.92±0.04、0.87±0.05 vs 0.95±0.05、0.81±0.03 vs 0.85±0.03,均P<0.01)。
- LS组第3、7天MI高于HS组(3.00±0.33 vs 2.60±0.29、4.50±0.51 vs 3.90±0.33),GET短于HS组(86.01±19.78 vs 100.99±25.01、71.00±16.37 vs 84.98±20.18分钟,均P<0.01)。
- 治疗3天后LS组TNF-α、IL-6、PCT、VEGF均低于HS组(TNF-α 147.05±28.32 vs 256.99±27.04 ng/L,IL-6 762.99±57.83 vs 1112.30±118.32 ng/L,PCT 37.00±5.58 vs 56.00±12.36 μg/L,VEGF 123.00±19.78 vs 167.01±21.55 ng/L,均P<0.05)。
- LS组血管活性药使用天数短于HS组(3.50±1.27 vs 4.55±1.47天),液体量少于HS组(1602.29±275.49 vs 2000.30±272.59 mL,均P<0.01)。
适用人群与场景
- 柳州市人民医院ICU 2019年1月1日至2020年5月31日收治的高血压脓毒性休克患者,共208例,LS组109例、HS组99例。
诊断标准与关键阈值
- 目标MAP:LS组65-70 mmHg(1 mmHg=0.133 kPa),HS组75-80 mmHg。
- 急性胃肠功能损伤(AGI)分级于第1、3、7天进行。
处置流程与药物剂量
- 所有患者按2016年拯救脓毒症运动指南及2018年更新版指南给予原发病治疗、液体复苏和支持治疗。
- LS组目标MAP 65-70 mmHg,HS组目标MAP 75-80 mmHg。
研究设计与关键结果
- 前瞻性随机对照研究,共纳入208例高血压脓毒性休克患者,LS组109例、HS组99例;两组诊断时性别、年龄、APACHE II评分、SOFA评分无显著差异。
- 第1天AGI分级两组无显著差异;第3天AGI I、II、III、IV级比例LS组分别为25.69%、56.88%、11.93%、5.50%,HS组分别为15.15%、54.55%、25.25%、5.05%(χ2=7.900,P=0.048);第7天LS组分别为44.96%、49.54%、3.67%、1.83%,HS组分别为31.31%、52.53%、11.11%、5.05%(χ2=8.178,P=0.042)。
- LS组第1、3、7天肠系膜上动脉Vm均高于HS组(21.72±3.02 vs 19.50±2.83、20.42±2.62 vs 17.02±1.99、26.52±2.70 vs 22.47±4.03 cm/s),RI均低于HS组(0.86±0.05 vs 0.92±0.04、0.87±0.05 vs 0.95±0.05、0.81±0.03 vs 0.85±0.03,均P<0.01)。
- LS组第3、7天MI高于HS组(3.00±0.33 vs 2.60±0.29、4.50±0.51 vs 3.90±0.33),GET短于HS组(86.01±19.78 vs 100.99±25.01、71.00±16.37 vs 84.98±20.18分钟,均P<0.01)。
- 治疗3天后LS组血清TNF-α、IL-6、PCT、VEGF水平均低于HS组(TNF-α 147.05±28.32 vs 256.99±27.04 ng/L,IL-6 762.99±57.83 vs 1112.30±118.32 ng/L,PCT 37.00±5.58 vs 56.00±12.36 μg/L,VEGF 123.00±19.78 vs 167.01±21.55 ng/L,均P<0.05)。
- 实际维持目标MAP:LS组(68.02±4.71)mmHg,HS组(79.04±3.04)mmHg,两组差异有统计学意义(P<0.01)。
- LS组血管活性药使用天数短于HS组(3.50±1.27 vs 4.55±1.47天),液体量少于HS组(1602.29±275.49 vs 2000.30±272.59 mL,均P<0.01)。
证据类型、等级与局限
- 证据类型:前瞻性随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高血压脓毒性休克患者维持低目标MAP(65-70 mmHg)可改善肠系膜上动脉血供、保护胃肠功能、降低炎症因子水平、缩短血管活性药使用时间并减少液体量。
指南或共识出处
- Surviving Sepsis Campaign Guidelines 2016(2016年拯救脓毒症运动指南)
- 2018年更新版拯救脓毒症运动指南
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of fluid resuscitation and circulatory support, directed by different target mean arterial pressure (MAP), on abdominal blood flow, gastrointestinal function and inflammatory response in septic shock patients with hypertension.
METHODS: A prospective randomized controlled study was conducted. Hypertensive patients with septic shock admitted to the department of intensive care unit (ICU) of Liuzhou People's Hospital from January 1, 2019 to May 31, 2020 were enrolled. Patients were randomly divided into the low MAP groups (low standard group, LS group) or high MAP group (high standard group, HS group). According to the Surviving Sepsis Campaign Guidelines in 2016 and the updated guideline in 2018, all patients were given treatment of primary disease, fluid resuscitation, supportive management. The target MAP was 65-70 mmHg (1 mmHg = 0.133 kPa) in LS group, and was 75-80 mmHg in HS group. Acute gastrointestinal function injury (AGI) classification was performed on the 1st, 3rd and 7th day. The mean flow rate (Vm) and resistance index (RI) of superior mesenteric artery were evaluated using ultrasound, and the gastrointestinal function was dynamically evaluated using the modified single section ultrasonic gastric antrum method. The gastric antrum movement index (MI) and gastric empaging time (GET) were recorded. The levels of inflammatory markers in serum were detected by enzyme linked immunosorbent assay (ELISA), such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), procalcitonin (PCT) and vascular endothelial growth factor (VEGF). The target MAP, the days of use of vasopressors and the amount of fluid resuscitation were recorded.
RESULTS: A total of 208 hypertensive patients with septic shock were enrolled, including 109 in the LS group and 99 in the HS group. There were no significant differences in gender, age, acute physiology and chronic health evaluation II (APACHE II) score and sequential organ failure assessment (SOFA) score between the two groups when diagnosed. After treatment, there was no significant difference in AGI classification between the LS group and HS group on the 1st day. On the 3rd and 7th day, there were statistical differences between the two groups (3rd day: proportion of I, II, III, IV grades were 25.69%, 56.88%, 11.93%, 5.50% in LS group, 15.15%, 54.55%, 25.25%, 5.05% in HS group, respectively, χ2 = 7.900, P = 0.048; 7rd day: proportion of I, II, III, IV grades were 44.96%, 49.54%, 3.67%, 1.83% in LS group, 31.31%, 52.53%, 11.11%, 5.05% in HS group, respectively, χ2 = 8.178, P = 0.042). The Vm of superior mesenteric artery was higher and the RI was lower in the LS group than those in the HS group on day 1, 3 and 7 [Vm (cm/s): 21.72±3.02 vs. 19.50±2.83, 20.42±2.62 vs. 17.02±1.99, 26.52±2.70 vs. 22.47±4.03; RI: 0.86±0.05 vs. 0.92±0.04, 0.87±0.05 vs. 0.95±0.05, 0.81±0.03 vs. 0.85±0.03, all P < 0.01]. The MI was higher and the GET was shorter in the LS group than those in the HS group on day 3 and day 7 [MI: 3.00±0.33 vs. 2.60±0.29, 4.50±0.51 vs. 3.90±0.33; GET (minutes): 86.01±19.78 vs. 100.99±25.01, 71.00±16.37 vs. 84.98±20.18, all P < 0.01]. In addition, the levels of serum TNF-α, IL-6, PCT, VEGF were lower in the LS group than those in the HS group after 3 days of treatment [TNF-α (ng/L): 147.05±28.32 vs. 256.99±27.04, IL-6 (ng/L): 762.99±57.83 vs. 1 112.30±118.32, PCT (μg/L): 37.00±5.58 vs. 56.00±12.36, VEGF (ng/L): 123.00±19.78 vs. 167.01±21.55, all P < 0.05]. The target MAP was maintained at (68.02±4.71) mmHg in LS group, and (79.04±3.04) mmHg in HS group. The difference between the two groups was statistically significant (P < 0.01). Compared with the HS group, the days of using vasopressors was shorter in LS group (days: 3.50±1.27 vs. 4.55±1.47), and the amountof fluid was reduced significantly (mL: 1 602.29±275.49 vs. 2 000.30±272.59, both P < 0.01).
CONCLUSIONS: Maintaining a low target mean arterial pressure (65-70 mmHg) in hypertensive patients with septic shock can improve blood supply of superior mesenteric artery, protect the gastrointestinal function, reduce the level of inflammatory factors, and diminish the duration of using vasopressors and the amount of fluid.
参考来源
- Zhu X, Hou J, Zhang Q, et al. [Effects of treatment based on different target mean arterial pressure on gastrointestinal function in septic shock patients with hypertension]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112285. doi:10.3760/cma.j.cn121430-20200713-00515
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。